Centro de Investigacion Biomedica en Red de Salud Mental-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2019

  1. Can interleukin-2 and interleukin-1β be specific biomarkers of negative symptoms in schizophrenia?

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 9-16

2018

  1. Oxidative stress biomarkers and clinical dimensions in first 10 years of schizophrenia

    Revista de Psiquiatria y Salud Mental, Vol. 11, Núm. 3, pp. 130-140

2013

  1. Mechanisms of cannabidiol neuroprotection in hypoxic-ischemic newborn pigs: Role of 5HT1A and CB2 receptors

    Neuropharmacology, Vol. 71, pp. 282-291